Screener
Neuropace, Inc. NPCE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s enterprise value?
- Neuropace, Inc. (NPCE) reported enterprise value of $598.9M in Q2 2026.
- How has Neuropace, Inc.'s enterprise value changed year-over-year?
- Neuropace, Inc.'s enterprise value increased by 49.2% year-over-year, from $401.45M to $598.9M.
- What is the long-term trend for Neuropace, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s enterprise value has grown at a 18.8% compound annual growth rate (CAGR), from $283.06M to $563.29M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Neuropace, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude